ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
4,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
5,1,Acne,Acnes,Skin appendage conditions,Skin,N
6,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
6,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6,3,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
7,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
8,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Brain stem infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
10,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
11,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
11,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
13,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
13,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
13,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
14,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
14,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
14,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
15,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
16,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
16,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
18,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
18,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
19,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
19,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
19,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
19,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
19,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
19,6,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
20,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
20,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
20,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
22,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
22,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
22,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
23,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,2,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
24,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
25,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
27,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
27,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
28,2,Headache,Headaches NEC,Headaches,Nerv,N
28,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
28,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
29,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
29,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,4,Scleral discolouration,"Scleral structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
29,5,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
30,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
30,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
30,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
30,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
32,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
33,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
34,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
34,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
34,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
35,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
36,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
36,2,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
37,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
37,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
37,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
38,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
39,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
39,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
40,1,Foetal cardiac disorder,Foetal complications NEC,Foetal complications,Preg,N
41,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
42,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
43,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
43,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
44,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
44,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,4,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
45,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
45,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
46,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
46,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
46,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
47,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
48,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
48,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
49,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
49,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
49,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
49,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
49,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
49,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
49,7,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
49,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
49,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,1,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
51,1,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
51,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
52,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
53,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
55,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
55,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
56,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
56,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
56,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
57,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
57,2,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
58,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
58,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
58,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
59,1,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
60,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
61,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
61,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
62,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
62,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
63,1,Hyperphosphatasaemia,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
64,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
65,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
66,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
66,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
67,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
67,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
67,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
68,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
69,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
69,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
69,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
69,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
69,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
70,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
71,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
72,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
74,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
75,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
75,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
76,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
77,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
77,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
78,1,Conduction disorder,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
78,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
79,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
79,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
79,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
79,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
79,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
79,6,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
79,7,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
80,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
80,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
80,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
80,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
80,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
80,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
80,7,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
80,8,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
80,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
81,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
82,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
83,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
83,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
84,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
84,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
85,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
85,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
85,3,Placental infarction,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
85,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
86,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
86,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
86,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
86,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
86,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
88,1,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
89,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
90,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
91,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
92,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
93,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
94,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
95,1,Myopathy,Myopathies,Muscle disorders,Musc,N
96,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
96,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
98,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
99,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
99,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
99,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
100,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
100,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
101,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
101,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
101,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
101,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
101,5,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
102,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
103,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
103,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
104,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
104,2,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
104,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
105,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
106,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
106,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
107,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
107,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
107,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
108,1,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
109,1,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
110,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
110,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
110,3,Placental infarction,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
110,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
111,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
112,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
113,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
114,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
115,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
115,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
115,3,Schistosomiasis,Trematode infections,Helminthic disorders,Infec,N
116,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
116,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
117,1,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
118,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
118,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
119,1,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
119,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
119,3,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
119,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
119,5,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
120,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
121,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
121,2,Headache,Headaches NEC,Headaches,Nerv,N
121,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
122,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
123,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
123,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
123,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
124,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
124,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
125,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
125,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
126,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
126,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
127,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
128,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
129,1,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
129,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
129,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
130,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
131,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
132,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
133,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
134,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
135,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
136,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
137,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
137,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
137,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
138,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
139,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
140,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
141,1,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
141,2,Headache,Headaches NEC,Headaches,Nerv,N
141,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
141,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
141,5,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
142,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
143,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
143,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
143,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
144,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
145,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
146,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
147,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
148,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
149,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
150,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
150,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
151,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
152,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
153,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
154,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
155,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
155,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
155,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
156,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
157,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
158,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
159,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
159,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
160,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
160,2,Headache,Headaches NEC,Headaches,Nerv,N
160,3,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
161,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
161,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
162,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
163,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
164,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
165,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
165,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
166,1,Central nervous system viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
166,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
167,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
168,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
169,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
170,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
171,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
171,2,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
172,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
172,2,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
173,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
173,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
174,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
175,1,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
175,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
176,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
176,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
176,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
177,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
177,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
178,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
178,2,Hyperbilirubinaemia neonatal,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
179,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
180,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
181,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
182,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
183,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
184,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
184,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
185,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
185,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
186,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
186,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
186,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
187,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
187,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
188,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
188,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
189,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
190,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
190,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
190,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
191,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
191,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
191,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
191,5,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
191,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
192,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
192,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
193,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
193,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
194,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
194,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
195,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
195,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
196,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
197,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
197,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
197,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
197,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
197,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
198,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
199,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
199,2,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
200,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
202,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
203,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
204,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
204,2,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
205,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
206,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
206,2,Headache,Headaches NEC,Headaches,Nerv,N
206,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
208,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
208,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
209,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
211,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
212,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
212,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
212,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
213,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
213,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
213,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
213,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
213,6,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
213,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
213,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
213,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
213,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
213,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
214,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
215,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
215,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
216,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
217,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
218,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
218,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
218,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
219,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
220,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
220,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
220,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
220,4,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
220,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
220,6,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
220,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
221,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
221,2,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
222,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
223,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
224,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
224,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
224,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
225,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
225,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
226,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
226,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
227,1,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
228,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
229,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
229,2,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
230,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
230,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
230,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
230,4,Haemophilic arthropathy,Arthropathies NEC,Joint disorders,Musc,N
230,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
231,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
231,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
231,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
231,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
231,5,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
232,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
232,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
232,3,Headache,Headaches NEC,Headaches,Nerv,N
232,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
232,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
232,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
232,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
232,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
233,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
233,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
233,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
233,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
233,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
233,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
233,7,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
234,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
234,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
234,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
235,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
235,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
235,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
236,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
236,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
237,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
238,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
238,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
239,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
240,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
241,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
242,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
242,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
243,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
243,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
244,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
244,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
245,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
245,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
245,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
245,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
245,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
246,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
247,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
248,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,2,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
248,3,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
249,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
249,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,3,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
249,4,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
249,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
249,6,Hyperosmolar state,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
249,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
250,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
251,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
251,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
252,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
252,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
253,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
253,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
253,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
253,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
253,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
253,6,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
253,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
253,8,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
253,9,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
253,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
254,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
254,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
255,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
256,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
257,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
257,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
257,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
258,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
259,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
259,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
260,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
261,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
262,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
263,1,Congenital ureterocele,Ureteric disorders congenital,Renal and urinary tract disorders congenital,Cong,N
263,2,Foetal cystic hygroma,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
263,3,Kidney duplex,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
263,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
264,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
264,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
265,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
266,1,Congenital teratoma,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
266,2,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
266,3,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
266,4,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
266,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
266,6,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
267,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
267,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
267,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
267,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
267,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
268,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
269,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
270,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
271,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
272,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
272,2,Lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
273,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
273,2,Lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
274,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
274,2,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
274,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
274,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
275,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
275,2,Lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
276,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
276,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
277,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
277,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
277,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
278,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
279,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
279,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
279,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
279,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
279,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
279,6,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
279,7,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
280,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
280,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
280,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
281,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
282,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
283,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
284,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
285,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
285,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
285,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
286,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
286,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
286,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
286,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
286,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
287,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
287,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
287,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
287,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
288,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
288,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
288,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
289,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
290,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
290,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
290,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
290,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
291,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
292,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
293,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
293,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
293,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
294,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
294,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
294,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
295,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
295,2,Lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
295,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
295,4,Muscle oedema,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
296,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
297,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
297,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
298,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
299,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
300,1,Ammonia increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
300,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
300,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
301,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
301,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
302,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
302,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
302,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
303,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
303,2,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
303,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
303,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
303,5,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
303,6,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
304,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
304,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
305,1,Epidermodysplasia verruciformis,Papilloma viral infections,Viral infectious disorders,Infec,N
305,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
306,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
307,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
307,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
308,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
309,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
309,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
310,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
311,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
312,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
312,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
313,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
314,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
314,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
314,3,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
315,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
315,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
316,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
317,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
317,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
318,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
318,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
318,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
319,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
320,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
320,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
321,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
322,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
323,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
323,2,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
323,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
323,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
323,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
323,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
323,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
324,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
325,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
325,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
325,3,Endoscopic retrograde cholangiopancreatography,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
326,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
327,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
327,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
327,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
327,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
328,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
328,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
328,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
328,4,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
328,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
328,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
328,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
328,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
329,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
329,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
329,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
330,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
330,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
330,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
330,4,Oropharyngeal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
330,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
330,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
331,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
331,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
331,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
331,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
331,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
332,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
333,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
333,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
333,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
333,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
334,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
335,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
336,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
337,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
337,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
338,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
338,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
338,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
339,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
339,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
339,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
341,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
341,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
341,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
341,4,Headache,Headaches NEC,Headaches,Nerv,N
342,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
342,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
342,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
342,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
343,1,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
344,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
345,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
345,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
345,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
346,1,Retinal aneurysm,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
347,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
347,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
347,3,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
348,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
348,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
348,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
350,1,Involuntary commitment,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
351,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
352,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
353,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
354,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
355,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
357,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
357,2,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
358,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
359,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
360,1,Arterial disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
360,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
361,1,Headache,Headaches NEC,Headaches,Nerv,N
361,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
362,1,Congenital hydrocephalus,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
362,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
363,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
363,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
364,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
364,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
365,1,Craniofacial deformity,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
365,2,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
365,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
365,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
365,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
365,6,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
365,7,Ultrasound antenatal screen,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
366,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
367,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
368,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
368,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
368,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
368,4,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
368,5,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
368,6,Single functional kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
369,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
369,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
369,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
370,1,Hepatic cytolysis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
371,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
371,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
371,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
371,4,Hyperbilirubinaemia neonatal,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
371,5,Intraventricular haemorrhage neonatal,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
371,6,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
371,7,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
371,8,Periventricular leukomalacia,Encephalopathies NEC,Encephalopathies,Nerv,N
371,9,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
371,10,Pulmonary haemorrhage neonatal,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
371,11,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
372,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
372,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
373,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
374,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
375,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
